Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Alkem introduces cetuximab under the trade name Cetuxa in India.

2.

younger kidney cancer survivors are more susceptible to heart problems.

3.

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

4.

Dual imaging capsule captures 3D tissue and blood vessel changes for early esophageal cancer diagnosis

5.

MRI can save rectal cancer patients from surgery, study suggests


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot